Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo L Gallardo-Blanco

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Experimental and Therapeutic Medicine|June 14, 2018
Uridine 5'-diphospho-glucronosyltrasferase: Its role in pharmacogenomics and human diseaseCelia N Sanchez-Dominguez, Hugo L Gallardo-Blanco, Mauricio A Salinas-Santander, et al.
Current Topics in Medicinal Chemistry|January 22, 2014
Nanoparticles vs cancer: a multifuncional toolCelia N Sanchez-Dominguez, Hugo L Gallardo-Blanco, Arturo A Rodriguez-Rodriguez, et al.
Pediatric Surgery International|August 11, 2018
A clinical-pathogenetic approach on associated anomalies and chromosomal defects supports novel candidate critical regions and genes for gastroschisisVictor M Salinas-Torres, Rafael A Salinas-Torres, Ricardo M Cerda-Flores, et al.
Molecular Medicine Reports|December 20, 2017
Nanoparticles for death‑induced gene therapy in cancer (Review)Jorge A Roacho-Perez, Hugo L Gallardo-Blanco, Margarita Sanchez-Dominguez, et al.
Nanomaterials (Basel, Switzerland)|October 27, 2023
Design and Characterization of pMyc/pMax Peptide-Coupled Gold Nanosystems for Targeting Myc in Prostate Cancer Cell LinesSamuel Longoria-García, Celia N Sánchez-Domínguez, Margarita Sánchez-Domínguez, et al.
Scientific Reports|July 12, 2020
Associations of nicotidamide-N-methyltransferase, FTO, and IRX3 genetic variants with body mass index and resting energy expenditure in Mexican subjectsMaciel Bañales-Luna, Nicté Figueroa-Vega, Carolina Ivet Marín-Aragón, et al.
International Journal of Dermatology|June 6, 2014
An investigation into the MMP1 gene promoter region polymorphism--1607 2G with recessive dystrophic epidermolysis bullosa disease severity in northeastern Mexican patientsJorge Garza-Gómez, Ricardo M Cerda-Flores, Minerva Gómez-Flores, et al.
International Journal of Molecular Sciences|May 12, 2019
Bioinformatic Analysis of Gene Variants from Gastroschisis Recurrence Identifies Multiple Novel Pathogenetic Pathways: Implication for the Closure of the Ventral Body WallVíctor M Salinas-Torres, Hugo L Gallardo-Blanco, Rafael A Salinas-Torres, et al.
Molecular Genetics & Genomic Medicine|March 13, 2020
Whole exome sequencing identifies multiple novel candidate genes in familial gastroschisisVíctor M Salinas-Torres, Hugo L Gallardo-Blanco, Rafael A Salinas-Torres, et al.
BMC Cancer|February 10, 2016
A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizersRafael B R León-Cachón, Jorge A Ascacio-Martínez, María E Gamino-Peña, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Experimental and Therapeutic Medicine|June 14, 2018
Uridine 5'-diphospho-glucronosyltrasferase: Its role in pharmacogenomics and human diseaseCelia N Sanchez-Dominguez, Hugo L Gallardo-Blanco, Mauricio A Salinas-Santander, et al.
Current Topics in Medicinal Chemistry|January 22, 2014
Nanoparticles vs cancer: a multifuncional toolCelia N Sanchez-Dominguez, Hugo L Gallardo-Blanco, Arturo A Rodriguez-Rodriguez, et al.
Pediatric Surgery International|August 11, 2018
A clinical-pathogenetic approach on associated anomalies and chromosomal defects supports novel candidate critical regions and genes for gastroschisisVictor M Salinas-Torres, Rafael A Salinas-Torres, Ricardo M Cerda-Flores, et al.
Molecular Medicine Reports|December 20, 2017
Nanoparticles for death‑induced gene therapy in cancer (Review)Jorge A Roacho-Perez, Hugo L Gallardo-Blanco, Margarita Sanchez-Dominguez, et al.
Nanomaterials (Basel, Switzerland)|October 27, 2023
Design and Characterization of pMyc/pMax Peptide-Coupled Gold Nanosystems for Targeting Myc in Prostate Cancer Cell LinesSamuel Longoria-García, Celia N Sánchez-Domínguez, Margarita Sánchez-Domínguez, et al.
Scientific Reports|July 12, 2020
Associations of nicotidamide-N-methyltransferase, FTO, and IRX3 genetic variants with body mass index and resting energy expenditure in Mexican subjectsMaciel Bañales-Luna, Nicté Figueroa-Vega, Carolina Ivet Marín-Aragón, et al.
International Journal of Dermatology|June 6, 2014
An investigation into the MMP1 gene promoter region polymorphism--1607 2G with recessive dystrophic epidermolysis bullosa disease severity in northeastern Mexican patientsJorge Garza-Gómez, Ricardo M Cerda-Flores, Minerva Gómez-Flores, et al.
International Journal of Molecular Sciences|May 12, 2019
Bioinformatic Analysis of Gene Variants from Gastroschisis Recurrence Identifies Multiple Novel Pathogenetic Pathways: Implication for the Closure of the Ventral Body WallVíctor M Salinas-Torres, Hugo L Gallardo-Blanco, Rafael A Salinas-Torres, et al.
Molecular Genetics & Genomic Medicine|March 13, 2020
Whole exome sequencing identifies multiple novel candidate genes in familial gastroschisisVíctor M Salinas-Torres, Hugo L Gallardo-Blanco, Rafael A Salinas-Torres, et al.
BMC Cancer|February 10, 2016
A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizersRafael B R León-Cachón, Jorge A Ascacio-Martínez, María E Gamino-Peña, et al.
Pageof 2